drug

OriCAR-017

Phase 2updated 3mo ago

by Oricell Therapeutics (Shanghai) Co Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying OriCAR-017

phase1A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Studyrecruitingn=81
phase2OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMMrecruitingn=83

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

OriCAR-017

Phase 2updated 3mo ago

by Oricell Therapeutics (Shanghai) Co Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying OriCAR-017

phase1A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Studyrecruitingn=81
phase2OriCAR-017 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of R/RMMrecruitingn=83

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 12m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

OriCAR-017

all catalysts(0)

Trials studying OriCAR-017

News(0)

Report a data issue

comments(0)

OriCAR-017

all catalysts(0)

Trials studying OriCAR-017

News(0)

Report a data issue

comments(0)